Search results
Results from the WOW.Com Content Network
By their usual definitions, childhood dementias always cause global neurocognitive decline. In some childhood dementia conditions the child's early development is indistinguishable from their healthy peers, then slows or plateaus before declining. In other childhood dementia disorders, early development may be slower than typical before declining.
Dementia is a devastating condition that impacts up to 10 percent of older adults. And while there's no cure, getting diagnosed early can help patients get on a treatment plan and families prepare ...
Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).
Dementia with Lewy bodies (DLB) is a type of dementia, a group of diseases involving progressive neurodegeneration of the central nervous system. [11] It is one of the two Lewy body dementias, along with Parkinson's disease dementia. [12] Dementia with Lewy bodies can be classified in other ways.
The findings suggest that people born in the southern U.S. face a higher risk of developing dementia over time, along with people who are Black and Hispanic—although there are modifiable things ...
This isn’t the first time that better sleep has been linked with a lower risk of dementia: A study published in October even found that people with sleep apnea are more likely to develop dementia.
Pes cavus or high arched feet are an unusual finding in young children. Whilst some cavus foot types are familial and normally inherited, others are indicative of genetic neurological conditions, e.g. Charcot–Marie–Tooth disease [10] or Friedrich's ataxia. The appearance of high arched feet in young children should be noted. [clarification ...
As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, treatment and risk management that have been made in 2024.